Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Aurinia Pharmaceuticals Inc. AUPH

Full chart Compare
Set alert

Price alert · AUPH

All alert types
16.56 USD +0.42 (+2.60%)

At closeNov 3, 2026, 4:01 PM EST

16.56 0.00 0.00%

After hours · Nov 3, 4:01 PM ET

16.13 Day range 16.73
13.33 52-week range 19.25
YTD
+3.82%
1 year
+25.74%

Financial health

Altman Z-Score

8.80 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

6 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

A4 / 5 overall

  • DCF 3
  • Return on Equity 5
  • Return on Assets 5
  • Debt / Equity 3
  • P/E 4
  • P/B 2

Valuation

P/E 7.5×
FY 2016: -3.2×FY 2017: -5.3×FY 2018: -9.0×FY 2019: -15.2×FY 2020: -15.9×FY 2021: -16.3×FY 2022: -5.7×FY 2023: -16.6×FY 2024: 225×FY 2025: 7.5×
FY 2016 5y median -5.7× FY 2025
P/S 7.6×
FY 2016: 428×FY 2017: 888×FY 2018: 1249×FY 2019: 5927×FY 2020: 32.7×FY 2021: 64.9×FY 2022: 4.6×FY 2023: 7.3×FY 2024: 5.5×FY 2025: 7.6×
FY 2016 5y median 7.3× FY 2025
P/B 3.7×
FY 2016: 2.1×FY 2017: 2.3×FY 2018: 5.1×FY 2019: 6.3×FY 2020: 4.0×FY 2021: 6.2×FY 2022: 1.5×FY 2023: 3.4×FY 2024: 3.4×FY 2025: 3.7×
FY 2016 5y median 3.4× FY 2025
P/FCF 15.8×
FY 2016: -4.0×FY 2017: -9.1×FY 2018: -11.2×FY 2019: -29.6×FY 2020: -21.2×FY 2021: -18.6×FY 2022: -7.7×FY 2023: -37.7×FY 2024: 29.1×FY 2025: 15.8×
FY 2016 5y median -7.7× FY 2025
EV/EBITDA 16.7×
FY 2016: -1.6×FY 2017: -4.5×FY 2018: -8.5×FY 2019: -17.6×FY 2020: -13.4×FY 2021: -15.4×FY 2022: -5.1×FY 2023: -21.2×FY 2024: 40.4×FY 2025: 16.7×
FY 2016 5y median -5.1× FY 2025
EV/Sales 7.6×
FY 2016: 199×FY 2017: 494×FY 2018: 994×FY 2019: 4964×FY 2020: 27.4×FY 2021: 60.0×FY 2022: 3.9×FY 2023: 7.6×FY 2024: 5.4×FY 2025: 7.6×
FY 2016 5y median 7.6× FY 2025
FCF Yield 6.3%
FY 2016: -25.3%FY 2017: -11.0%FY 2018: -8.9%FY 2019: -3.4%FY 2020: -4.7%FY 2021: -5.4%FY 2022: -13.0%FY 2023: -2.7%FY 2024: 3.4%FY 2025: 6.3%
FY 2016 5y median -2.7% FY 2025

Profitability

Gross Margin 88.5%
FY 2016: 97.7%FY 2017: 99.8%FY 2018: -8837.8%FY 2019: 100.0%FY 2020: 100.0%FY 2021: 97.6%FY 2022: 95.8%FY 2023: 91.9%FY 2024: 88.0%FY 2025: 88.5%
FY 2016 5y median 91.9% FY 2025
Operating Margin 37.1%
FY 2016: -13187.3%FY 2017: -11205.5%FY 2018: -12129.2%FY 2019: -28598.4%FY 2020: -208.1%FY 2021: -396.3%FY 2022: -83.2%FY 2023: -52.2%FY 2024: -2.0%FY 2025: 37.1%
FY 2016 5y median -52.2% FY 2025
Net Margin 101.5%
FY 2016: -13465.3%FY 2017: -16855.2%FY 2018: -13848.8%FY 2019: -27794.0%FY 2020: -204.9%FY 2021: -396.8%FY 2022: -80.7%FY 2023: -44.5%FY 2024: 2.4%FY 2025: 101.5%
FY 2016 5y median -44.5% FY 2025
ROE 49.4%
FY 2016: -64.8%FY 2017: -42.7%FY 2018: -57.0%FY 2019: -29.6%FY 2020: -25.2%FY 2021: -37.8%FY 2022: -26.7%FY 2023: -20.6%FY 2024: 1.5%FY 2025: 49.4%
FY 2016 5y median -20.6% FY 2025
ROIC 15.5%
FY 2016: -46.5%FY 2017: -25.9%FY 2018: -40.5%FY 2019: -29.1%FY 2020: -24.1%FY 2021: -35.9%FY 2022: -26.2%FY 2023: -18.8%FY 2024: -0.8%FY 2025: 15.5%
FY 2016 5y median -18.8% FY 2025
ROA 38.2%
FY 2016: -40.9%FY 2017: -37.3%FY 2018: -44.0%FY 2019: -27.3%FY 2020: -22.1%FY 2021: -33.3%FY 2022: -23.0%FY 2023: -14.2%FY 2024: 1.0%FY 2025: 38.2%
FY 2016 5y median -14.2% FY 2025

Growth (YoY)

Revenue 20.4%
FY 2016: -26.4%FY 2017: 142.8%FY 2018: 10.2%FY 2019: -31.3%FY 2020: 15660.4%FY 2021: -9.0%FY 2022: 193.9%FY 2023: 31.0%FY 2024: 34.0%FY 2025: 20.4%
FY 2016 FY 2025
Operating Income 2338.4%
FY 2016: 3.2%FY 2017: -106.3%FY 2018: -19.3%FY 2019: -61.9%FY 2020: -14.7%FY 2021: -73.3%FY 2022: 38.3%FY 2023: 17.7%FY 2024: 94.9%FY 2025: 2338.4%
FY 2016 FY 2025
EPS (diluted) 5167.2%
FY 2016: -13.8%FY 2017: -39.4%FY 2018: 17.4%FY 2019: -75.0%FY 2020: 34.6%FY 2021: -60.9%FY 2022: 45.7%FY 2023: 28.9%FY 2024: 107.3%FY 2025: 5167.2%
FY 2016 FY 2025
Free Cash Flow 207.0%
FY 2016: -5.2%FY 2017: -119.8%FY 2018: -25.5%FY 2019: -23.2%FY 2020: -21.2%FY 2021: -106.2%FY 2022: 49.9%FY 2023: 57.2%FY 2024: 229.0%FY 2025: 207.0%
FY 2016 FY 2025

Financial Health

Current Ratio 5.2×
FY 2016: 5.2×FY 2017: 21.5×FY 2018: 18.3×FY 2019: 27.9×FY 2020: 13.1×FY 2021: 12.6×FY 2022: 9.6×FY 2023: 5.5×FY 2024: 4.6×FY 2025: 5.2×
FY 2016 5y median 5.5× FY 2025
Quick Ratio 4.8×
FY 2016: 5.2×FY 2017: 21.5×FY 2018: 18.3×FY 2019: 27.9×FY 2020: 12.7×FY 2021: 12.2×FY 2022: 9.1×FY 2023: 5.0×FY 2024: 4.2×FY 2025: 4.8×
FY 2016 5y median 5.0× FY 2025
Debt / Equity 0.1×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.3×FY 2024: 0.2×FY 2025: 0.1×
FY 2016 5y median 0.1× FY 2025
Net Debt / EBITDA -0.0×
FY 2016: 1.9×FY 2017: 3.6×FY 2018: 2.2×FY 2019: 3.4×FY 2020: 2.6×FY 2021: 1.3×FY 2022: 0.8×FY 2023: -0.8×FY 2024: -0.1×FY 2025: -0.0×
FY 2016 5y median -0.0× FY 2025
Interest Coverage 24.2×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: -33.0×FY 2024: -1.0×FY 2025: 24.2×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31